medigraphic.com
Órgano Ofical de la Facultad de Estomatología de la Benemérita Universidad Autónoma de Puebla

2018, Number 60

<< Back Next >>

Oral 2018; 19 (60)

Patient approach with Henoch-Schönlein Purpura at the Pediatric Stomatology Clinic of the UASLP

Bedolla-Gaxiola HA, Hernández-Molinar Y

Language: Spanish
References: 17
Page: 1590-1593
PDF size: 94.34 Kb.


ABSTRACT

Henoch-Schönlein purpura is the vasculitis that occurs mostly in children between two and six years, has a worldwide incidence between 10.5 and 20.4 cases per 100 thousand children per year. He has a predilection for male sex, finding a 1.2: 1 relationship. With an incidence 10 times higher in children of Hispanic descent than in African-Americans and Caucasians. The diagnosis is made based on a series of clinical criteria proposed by the European Society of Pediatric Rheumatology (PRES) and the European League Against Rheumatism (EULAR). The diagnosis is based on clinical criteria, the use of complementary studies is carried out as part of the protocol focused on corroborating the state of the disease and the degree of involvement in which the patient is or can develop. For dental treatment, prophylactic treatment is always necessary.


REFERENCES

  1. Camacho Lovillo MS, Lirola Cruz MJ. Púrpura de Shönlein- Henoch, enfermedad de Kawasaki y otras vasculitis. Pediatr Integr 2017; 21(3):183-95.

  2. Willan R. Y P RÁCTICA Historia de la púrpura de Henoch- Schönlein. Acta Medica Colombiana 32(2): 97-100.

  3. Piram M, Mahr A. Epidemiology of immunoglobulin A vasculitis (Henoch-Schönlein): current state of knowledge. Curr Opin Rheumatol 2013; 25(2): 171-78.

  4. McCarthy HJ, Tizard EJ. Clinical practice: Diagnosis and management of Henoch-Schönlein purpura. Eur J Pediatr. 2010;169(6): 643-50.

  5. Gardner-Medwin JMM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 2002; 360(9341): 1197-202.

  6. Cáceres-Mosquera DJ, Fuentes-Velasco DY, Romero-Navarro B. Púrpura de Henoch-Schönlein. Reporte de 105 pacientes pediátricos. Bol Med Hosp Infant Mex 2006; 63: 314-21.

  7. Ma. Dolores López Saldaña. Púrpura de Schönlein-Henoch. Reumatología; 81-84.

  8. Escoda Mora Jaume, et al. Púrpura de Schönlein- Henoch. A propósito de un caso en una deportista. Apunts. MEDICINA DE L’ESPORT 2017; 41(152): 151-54.

  9. Jaulhola O. Henoch-Schönlein purpura in children. 2012.

  10. Chen O, Xb Z, Ren P, Yb W, Rp S, De W. Henoch Schönlein Purpura in children : clinical analysis of 120 cases. 2013;13(1): 5-10.

  11. Ricart Campos S. Púrpura de Schönlein-Henoch. Protoc diagn ter pediatr 2014; 1: 131-40.

  12. Trnka P. Henoch-Schönlein purpura in children. J Paediatric Child Health 2013; 49(12): 995-1003.

  13. Pan Y, Ye Q, Shao W, Shang S, Mao J, et al. Relationship between Immune Parameters and Organ Involvement in Children with Henoch-Schönlein Purpura. PLoS ONE 2014; 9(12): 1-12.

  14. Tarvin SE, Ballinger S. Henoch-Schönlein purpura. Current Paediatrics 2006;16(4): 259-63.

  15. Ceballos-Hernández H, et al. Tratamiento estomatológico interdisciplinario del lupus eritematoso generalizado. Acta pediatr. Mex 2015; 36(4): 330-36.

  16. Kang Y, Park J, Ha Y, Kang M, Park H, Lee S, et al. Differences in Clinical Manifestations and Outcomes between Adult and Child Patients with Henoch-Schönlein Purpura. J Korean Med Sci 2014; 29(2): 198-203.

  17. Gutiérrez J, Bagán J, Bascones A, Llamas R, Llena J, Morales A, et al. Documento de consenso sobre la utilización de profilaxis antibiótica en cirugía y procedimientos dentales. Av Odontoestomatol 2006; 22(1): 41-67.




2020     |     www.medigraphic.com